Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis Intest Res. 2025;23(2):144-156 Histologic remission is increasingly recognized as an important objective in the management of ulcerative colitis (UC). However, histologic evaluation requires invasive procedures, prompting interest in fecal calprotectin (FC) as a non-invasive surrogate marker. In this prospective observational cohort study (n = 347), patients with UC underwent concurrent clinical, endoscopic, biochemical, and histologic evaluations. Four histologic indices (Geboes Score (GS), Continuous GS, Nancy Index (NI), and Robarts Histopathology Index (RHI)) were evaluated for internal concordance and their correlation with FC concentrations. The concordance between different histologic indices was high. FC levels demonstrated fair correlations with clinical, endoscopic, and histologic parameters. Notably, an FC threshold below 100 μg/g predicted histologic remission with greater than 80% accuracy, irrespective of the histologic scoring system applied. These results underscore the potential of FC as a reliable, non-invasive biomarker indicative of histologic remission. ![]() |
|
Read more about predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis Best regards, |